Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

6.74
BATS BZX Real-Time Price
As of 12:30pm ET
 +0.12 / +1.81%
Today’s Change
2.80
Today|||52-Week Range
10.51
+33.47%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Neylan John F /keryx/
Chief Medical Officer
Buy8/12/201510,000$6.20$62.0K+4.64%
Madison Gregory P
President & Chief Executive Officer
Buy8/20/20159,984$5.69$56.8K+22.02%
Holmes Scott A
Chief Financial Officer
Buy8/21/20155,000$5.72$28.6K+17.57%
Neylan John F /keryx/
Chief Medical Officer
Sale4/25/20164,766$5.21$24.8K+28.52%
Holmes Scott A
Chief Financial Officer
Sale7/31/20152,758$7.87$21.7K-15.29%
Madison Gregory P
President & Chief Executive Officer
Sale1/06/20164,261$4.83$20.6K+52.94%
Holmes Scott A
Chief Financial Officer
Buy11/03/20153,672$5.30$19.5K+25.19%
Oliviero James F Iii
Chief Financial Officer
Sale7/06/20151,943$9.61$18.7K-30.17%
Adams Brian R
Vice President & General Counsel
Sale1/05/20163,003$4.83$14.5K+40.83%
Adams Brian R
Vice President & General Counsel
Sale7/15/20151,086$9.99$10.8K-31.85%
Page of 3